Flex Pharma, Inc. Business Finance Contracts & Agreements
28 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Investor Rights Agreements (1)
- Purchase Agreements (3)
- Registration Rights Agreements (2)
- Stock Agreements (7)
- Underwriting Agreements (6)
- Warrant Agreements (7)
- Notice of Stock Option Amendment, dated February 20, 2024, by and between Salarius Pharmaceuticals, Inc. and David J. Arthur (Filed With SEC on February 23, 2024)
- Amended and Restated Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan (Filed With SEC on June 15, 2023)
- Form of Registration Rights Agreement (Filed With SEC on May 16, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on May 16, 2023)
- Form of Common Stock Warrants (Filed With SEC on May 16, 2023)
- Securities Purchase Agreement dated April 22, 2022 (Filed With SEC on April 22, 2022)
- Form of Warrant (Filed With SEC on April 22, 2022)
- Form of Warrant (Filed With SEC on July 1, 2021)
- Underwriting Agreement, March 4, 2021, between Salarius Pharmaceuticals, Inc. and Ladenburg Thalmann & Co. Inc., as representative of the several underwriters (Filed With SEC on March 8, 2021)
- Form of Inducement Warrant (Filed With SEC on December 11, 2020)
- Form of Inducement Warrant (Filed With SEC on December 11, 2020)
- Underwriting Agreement, July 30, 2020, between Salarius Pharmaceuticals, Inc. and Ladenburg Thalmann & Co. Inc., as representative of the several underwriters (Filed With SEC on August 3, 2020)
- Salarius Pharmaceuticals, Inc., 2015 Employee Stock Purchase Plan, as amended (Filed With SEC on June 19, 2020)
- Common Stock Purchase Warrant dated February 11, 2020 (Filed With SEC on February 12, 2020)
- Underwriting Agreement, dated February 7, 2020, between Salarius Pharmaceuticals, Inc. and Ladenburg Thalmann & Co. Inc., as representative of the several underwriters (Filed With SEC on February 12, 2020)
- Form of Preferred Stock Certificate of Registrant (Filed With SEC on February 6, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on February 6, 2020)
- Form of Underwriting Agreement (Filed With SEC on February 6, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on January 28, 2020)
- Form of Underwriting Agreement (Filed With SEC on January 28, 2020)
- Common Stock Purchase Agreement, dated October 24, 2019 between Salarius Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 28, 2019)
- Registration Rights Agreement, dated October 24, 2019, between Salarius Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 28, 2019)
- Asset Purchase Agreement dated July 23, 2019 by and among Salarius Pharmaceuticals, Inc., Flex Innovation Group LLC and Cliff-Cartwright Corporation (Filed With SEC on July 24, 2019)
- [ ] Flex Pharma, Inc. Common Shares UNDERWRITING AGREEMENT (Filed With SEC on January 20, 2015)
- FLEX PHARMA, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: [ ], 2015 APPROVED BY THE STOCKHOLDERS: [ ], 2015 (Filed With SEC on January 13, 2015)
- PATENT ASSIGNMENT AGREEMENT (Filed With SEC on December 29, 2014)
- TECHNOLOGY ASSIGNMENT AGREEMENT (Filed With SEC on December 29, 2014)
- AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on December 29, 2014)
